Paraffin-embedded samples routinely stored in most pathology departments provide investigators access to a variety of tissue samples for renal cell carcinoma (RCC). A variety of molecular pathways ...

Background: Cytotoxic chemotherapy has not been well investigated in non-clear-cell renal cell carcinoma (RCC ... papillary and 1 had collecting duct histology. The patient with collecting ...

(UroToday.com) The 2023 GU ASCO annual meeting included an oral abstract session on renal cell carcinoma (RCC), featuring a presentation ... prior to surgery: Blinded central histology review ...

Zanzalintinib (XL092) developed by Exelixis Inc | Colorectal cancer, renal cell carcinoma and squamous cell carcinoma ... including approval for nccRCC histology and a broader patient population.

Trial findings show long-term recurrence-free survival in patients with low-grade upper tract urothelial cancer treated with ...

MUSK, a vision-language model, enhances cancer diagnosis by integrating multimodal data, outperforming existing methods in ...

She underwent a radical nephrectomy, and histology was confirmed asmetastatic classic ... it is imperative to distinguish between breast AdCC metastasis and primary cystic renal cell carcinoma to be ...

Chemotherapeutic agents are often used to treat cancer. They combat tumor growth, but also have a number of undesirable side ...

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, and understanding the ...

Treatment for renal cell carcinoma can vary depending on the size of your tumor, your overall health, how advanced your cancer is, and other factors. Some of the options include surgery, radiation ...

In patients with advanced clear cell renal cell carcinoma (ccRCC), sitravatinib (tyrosine kinase inhibitor) has shown efficacy both alone and in combination with nivolumab (anti-PD-1). Here ...

Benefits include better discrimination between risk levels. (HealthDay News) — Patient-centered pathology reports (PCPR) help patients to understand prostate cancer results better than current ...